Medine.co.uk

Out of date information, search another

Montelukast 10 Mg Film-Coated Tablets

Out of date information, search another
Informations for option: Montelukast 10 Mg Film-Coated Tablets, show other option
Document: document 23 change

amneal'

PHARMACEUTICALS

PACKAGE LEAFLET: INFORMATION FOR THE USER

Montelukast 10 mg film-coated tablets

(Montelukast)

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

-    Keep this leaflet. You may need to read it again.

-    If you have any further questions, ask your doctor or pharmacist.

-    This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

-    If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

What is in this leaflet:

1.    What Montelukast is and what it is used for

2.    What you need to know before you take Montelukast

3.    How to take Montelukast

4.    Possible side effects

5.    How to store Montelukast

6.    Contents of the pack and other information

1. What Montelukast is and what is it used for

Montelukast is a leukotriene receptor antagonist that blocks substances called leukotrienes.

Leukotrienes cause narrowing and swelling of airways in the lungs and also cause allergy symptoms.

By blocking leukotrienes, Montelukast improves asthma symptoms, helps control asthma and improves seasonal allergy symptoms (also known as hay fever or seasonal allergic rhinitis).

Your doctor has prescribed Montelukast to treat asthma, preventing your asthma symptoms during the day and night.

-    Montelukast is used for the treatment of patients who are not adequately controlled on their medication and need additional therapy.

-    Montelukast also helps prevent the narrowing of airways triggered by exercise.

-    In those asthmatic patients in whom Montelukast is indicated in asthma, Montelukast can also provide symptomatic relief of seasonal allergic rhinitis.

Your doctor will determine how Montelukast should be used depending on the symptoms and severity of your asthma.

What is asthma?

Asthma is a long-term disease.

Asthma includes:

-    difficulty breathing because of narrowed airways. This narrowing of airways worsens and improves in response to various conditions.

-    sensitive airways that react to many things, such as cigarette smoke, pollen, cold air, or exercise.

-    swelling (inflammation) in the lining of the airways.

Symptoms of asthma include: Coughing, wheezing, and chest tightness.

What are seasonal allergies?

Seasonal allergies (also known as hay fever or seasonal allergic rhinitis) are an allergic response often caused by airborne pollens from trees, grasses and weeds. The symptoms of seasonal allergies typically may include: stuffy, runny, itchy nose; sneezing; watery, swollen, red, itchy eyes.

2. What you need to know before you take Montelukast

Tell your doctor about any medical problems or allergies you have now or have had. Do not take Montelukast

-    if you are allergic (hypersensitive) to montelukast or any of the other ingredients of Montelukast (see 6. Further information).

Warnings and precautions

-    If your asthma or breathing gets worse, tell your doctor immediately.

-    Oral Montelukast is not meant to treat acute asthma attacks. If an attack occurs, follow the instructions your doctor has given you. Always have your inhaled rescue medicine for asthma attacks with you.

-    It is important that you or your child take all asthma medications prescribed by your doctor. Montelukast should not be substituted for other asthma medications your doctor has prescribed for you.

-    Any patient on anti-asthma medicines should be aware that if you develop a combination of symptoms such as a flu-like illness, pins and needles or numbness of arms or legs, worsening of pulmonary symptoms, and/or rash, you should consult your doctor.

-    You should not take acetyl-salicylic acid (aspirin) or anti-inflammatory medicines (also known as non-steroidal anti-inflammatory drugs or NSAID's) if they make your asthma worse.

Use in children

For children 2 to 5 years old, Montelukast Paediatric 4 mg chewable tablets are available.

For children 6 to 14 years old, Montelukast Paediatric 5 mg chewable tablets are available.

Other medicines and Montelukast

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Some medicines may affect how Montelukast works, or Montelukast may affect how other medicines work.

Tell your doctor if you are taking the following medicines before starting Montelukast:

-    phenobarbital (used for treatment of epilepsy)

-    phenytoin (used for treatment of epilepsy)

-    rifampicin (used to treat tuberculosis and some other infections)

Montelukast with food and drink

Montelukast may be taken with or without food.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Use in pregnancy

Women who are pregnant or intend to become pregnant should consult their doctor before taking Montelukast. Your doctor will assess whether you can take Montelukast during this time.

Use in breast-feeding

It is not known if Montelukast appears in breast milk. You should consult your doctor before taking Montelukast if you are breast-feeding or intend to breast-feed.

Driving and using machines

Montelukast is not expected to affect your ability to drive a car or operate machinery. However, individual responses to medication may vary. Certain side effects (such as dizziness and drowsiness) that have been reported very rarely with Montelukast may affect some patients ability to drive or operate machinery.

Montelukast 10 mg film-coated tablets contain lactose.

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

3. How to take Montelukast

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

-    You should take only one tablet of Montelukast once a day as prescribed by your doctor.

-    It should be taken even when you have no symptoms or have an acute asthma attack.

-    To be taken by mouth

For adults 15 years of age and older:

One 10 mg tablet to be taken daily in the evening. Montelukast may be taken with or without food.

If you are taking Montelukast, be sure that you do not take any other products that contain the same active ingredient, montelukast.

If you take more Montelukast than you should

Contact your doctor immediately for advice.

There were no side effects reported in the majority of overdose reports. The most frequently occurring symptoms reported with overdose in adults and children included abdominal pain, sleepiness, thirst, headache, vomiting, and hyperactivity.

If you forget to take Montelukast

Try to take Montelukast as prescribed. However, if you miss a dose, just resume the usual schedule of one tablet once daily.

Do not take a double dose to make up for a forgotten dose.

If you stop taking Montelukast

Montelukast can treat your asthma only if you continue to take it.

It is important to continue taking Montelukast for as long as your doctor prescribes. It will help control your asthma.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

In clinical studies with montelukast 10 mg film-coated tablets, the most commonly reported side effects (occurring in at least 1 of 100 patients and less than 1 of 10 patients treated) thought to be related to Montelukast were:

-    abdominal pain

-    headache

These were usually mild and occurred at a greater frequency in patients treated with montelukast than placebo (a pill containing no medication).

The frequency of possible side effects listed below is defined using the following convention:

Very common (affects at least 1 user in 10)

Common    (affects    1    to 10 users in    100)

Uncommon    (affects    1    to 10 users in    1,000)

Rare    (affects    1    to 10 users in    10,000)

Very rare    (affects    less than 1 user    in 10,000)

Additionally, while the medicine has been on the market, the following have

been reported:

-    upper respiratory infection (Very common)

-    increased bleeding tendency (Rare)

-    allergic reactions including rash, swelling of the face, lips, tongue, and/or throat which may cause difficulty in breathing or swallowing (Uncommon)

-    behaviour and mood related changes [dream abnormalities, including nightmares, trouble sleeping, sleep walking, irritability, feeling anxious, restlessness, agitation including aggressive behaviour or hostility, depression (Uncommon); tremor (Rare); hallucinations, suicidal thoughts and actions (Very rare)\

-    dizziness, drowsiness, pins and needles/numbness, seizure (Uncommon)

-    palpitations (Rare)

-    nosebleed (Uncommon)

-    diarrhoea, nausea, vomiting (Common); dry mouth, indigestion (Uncommon)

-    hepatitis (inflammation of the liver) (Veryrare)

-    bruising, itching, hives Uncommon); tender red lumps under the skin most commonly on your shins (erythema nodosum) (Very rare),

-    joint or muscle pain, muscle cramps Uncommon)

-    fever (Common); tiredness, feeling unwell, swelling Uncommon)

6. Contents of the pack and other information What Montelukast contains

-    The active substance is montelukast. Each tablet contains montelukast sodium which corresponds to 10 mg of montelukast.

-    The other ingredients are:

Tablet Core: Cellulose, microcrystalline (E460), lactose monohydrate, croscarmellose sodium, hydroxypropyl cellulose (E463), magnesium stearate (E572).

Film coating: hydroxylpropyl cellulose (E463), hypromellose 6cP (E464), titanium dioxide (E171), iron oxide yellow (E172), carnuba wax (E903), iron oxide red (E172).

What Montelukast looks like and contents of the pack

Film-coated tablets

Beige coloured, rounded square shaped, film-coated tablets debossed with 'X' on one side and '54' on other side.

Blister packs of Polyamide / Aluminium foil / PVC - Aluminium foil blisters Pack sizes: 14, 20, 28, 30, 50, 56, 98, 100 tablets

HDPE bottle with polypropylene cap containing silica gel desiccant:

Pack sizes: 30 tablets

Not all listed pack sizes will be marketed.

Marketing Authorisation Holder

Amneal Pharma Europe Limited 70 Sir John Rogerson's Quay Dublin 2 Ireland

Manufacturer

APL Swift Services (Malta) Limited.

HF26, Hal Far Industrial Estate, Hal Far,

Birzebbugia, BBG 3000, Malta

This leaflet was last updated in 05/2014

In asthmatic patients treated with montelukast, very rare cases of a combination of symptoms such as flu-like illness, pins and needles or numbness of arms and legs, worsening of pulmonary symptoms and/or rash (Churg-Strauss syndrome) have been reported. You must tell your doctor right away if you get one or more of these symptoms.

Ask your doctor or pharmacist for more information about side effects.

If you get any side effects, talk to your doctor or pharmacist. This includes any side effects not listed in this leaflet.

5. How to store Montelukast

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date, which is stated on the carton/label/ bottle after EXP. The expiry date refers to the last date of that month.

Store below 250C.

Store in the original package in order to protect from light and moisture.

Use within 30 days after first opening the HDPE bottle.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.